Compared to cancers with neutral copy numbers of MYC, breast cancers with amplified MYC contained lower fractions of monocytes, M2 macrophages and CD8+ T cells, whereas they showed increased fractions of M0/M1 macrophages and regulatory T cells (Supplementary Fig. S3D). This evidence concerns the gene MYC and breast carcinoma.